Skip to content

BreezeBio vs ReCode Therapeutics

BreezeBio logo

BreezeBio

Genetic Medicine Delivered

65 employees · est. 2016 · Brisbane, United States

VS
ReCode Therapeutics logo

ReCode Therapeutics

Powering the next wave of genetic medicines through superior delivery

58 employees · est. 2015 · United States

ReCode Therapeutics is the older company (2016 vs 2015).

Side-by-Side Comparison

BreezeBio ReCode Therapeutics
Founded
2016 2015 older
Headquarters
Brisbane, United States United States
Employees
65 58
Industry
Biotechnology, Health and Wellness, Pharmaceutical Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Series A Series B
Total Funding
$67.73M $347.50M
Funding Rounds
7 8
Services
Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies Targeted Delivery of Genetic Medicines, Development of Rare Disease Therapeutics, SORT Lipid Nanoparticle Platform
Target Customers
Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies Patients with Genetically Defined Diseases, Healthcare Providers, Biotech and Pharmaceutical Partners
Taxonomy
Genetic MedicinesGene Therapy DeliveryPolymer NanoparticlesNon-Viral Gene EditingTherapeutic CandidatesNanoGalaxy Platform +9 Genetic MedicinesMRNA TherapeuticsGene CorrectionLipid NanoparticlesSelective Organ TargetingSORT Platform +6
Website
genedit.com recodetx.com
BreezeBio logo

About BreezeBio

GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential of genetic medicines". The company addresses a critical bottleneck in the field—effective delivery...

ReCode Therapeutics logo

About ReCode Therapeutics

ReCode Therapeutics, founded in 2015, is leading innovations in the biopharma sector with its focus on genetic medicines. Based in the United States, this clinical-stage company is setting a benchmark in the Biotechnology and Pharmaceutical industries. With the slogan "Powering the next wave of gen...

Also comparing in this category

Comparing more than these two?

Get BreezeBio, ReCode Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does BreezeBio compare?

A PDF of BreezeBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

BreezeBio was founded in 2016, based in Brisbane, United States, with 65 employees. GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential. ReCode Therapeutics was founded in 2015, based in United States, with 58 employees. ReCode Therapeutics, founded in 2015, is leading innovations in the biopharma sector with its focus on genetic medicines. Based in the United States, this clinical-stage company is setting a benchmark.
BreezeBio has raised $67.73M and ReCode Therapeutics $347.50M. Latest stage: BreezeBio Series A, ReCode Therapeutics Series B.
Both work in Biotechnology and Pharmaceutical and list genetic medicines among their focus areas.

Compare BreezeBio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BreezeBio on 15 Jun 2026, and ReCode Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout